Skip to main content

Researchers identify strategy to block immunosuppressive signals in melanoma

September 16, 2019

Cancer cells have a clever approach to avoid key immune cells intent on killing them. Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center report in the journal Cancer Immunology Research they have developed a strategy to shut down signals that keep cancer-killing immune cells from infiltrating melanoma. By blocking receptors on the … Continued

Patients, researchers seek melanoma solutions

July 2, 2019

Ten years after he first discovered cancerous brown marks growing on his shoulder, Michael Martin learned the skin cancer was back. He already had the melanoma removed surgically twice, but the cancer came back a third time, and it had spread. Now the cancer was on his lung — the cancerous cells were surgically removed … Continued

Melanoma Patient Day symposium to include talks on treatment, nutrition

April 30, 2019

The University of North Carolina Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital are partnering with the Melanoma Research Foundation to host Melanoma Patient Day, an afternoon symposium offering information and support for patients with melanoma. The event will be held May 6 from 12:30 to 4:30 p.m. at the William and Ida Friday … Continued

Genetic features linked to higher melanoma risk, study confirms

March 27, 2019

Blistering sunburns, fair skin and a family history of skin cancer are known risk factors for developing melanoma, the deadliest form of skin cancer. A new study led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher confirms that certain inherited genetic features are also linked to a person’s melanoma risk. In a … Continued

New studies aim to improve melanoma diagnosis

February 28, 2019

A pair of studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers could aid in improved diagnosis for melanoma, the deadliest form of skin cancer. The studies, led by UNC Lineberger’s Nancy Thomas, MD, PhD, Irene & Robert Alan Briggaman Distinguished Professor and Chair in the UNC School of Medicine Department of … Continued

Researchers review metastatic melanoma treatment

February 15, 2019

Researchers led by UNC Lineberger’s David Ollila, MD, FACS, the James H. and Jesse E. Millis Distinguished Professor in the UNC School of Medicine Division of Surgical Oncology, reviewed the results for 80 adult metastatic melanoma patients treated with talimogene laherparepvec, or TVEC. Injection of TVEC effectively treated almost 40 percent of patients with tumors … Continued

Melanoma survivors share stories of recovery amid treatment advances

May 29, 2018

UNC Lineberger and the Melanoma Research Foundation hosted “Understanding Melanoma: From Prevention to Treatment,” a seminar for patients and caregivers at the William and Ida Friday Center for Continuing Education in Chapel Hill. Physicians, researchers, patients and staff spoke about advances in treatment and care for melanoma, research and prevention, as well as best practices to address the psychosocial aspects of care.

Advances in melanoma treatment focus of UNC conference

February 12, 2016

At the 10th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, experts in melanoma treatment presented advances in treating the disease on Thursday. The conference, held at the William and Ida Friday Center for Continuing Education, drew dermatologists, surgeons, medical oncologists and other health care providers to hear presentations on topics ranging from immunotherapy drugs and targeted treatments for metastatic disease, radiation strategies, and chemotherapy to prevent skin cancer.

Working wonders

August 18, 2015

UNC Lineberger member Frances Collichio, MD, was an investigator for a clinical trial for a treatment that uses a modified virus against melanoma. The treatment meant remission for Willis Davis, who had been diagnosed with stage IIIc melanoma in 2009.